1.
Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. I. Methods, safety, and clinical implications
by JOSEPH, Patricia M
Human gene therapy, 2001, Vol.12 (11), p.1369-1382

2.
Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. II. Transfection efficiency in airway epithelium
by PERRICONE, Michael A
Human gene therapy, 2001, Vol.12 (11), p.1383-1394

3.
A genome-wide association study of plasma total IgE concentrations in the Framingham Heart Study
by Granada, Mark, MD
Journal of allergy and clinical immunology, 2011, Vol.129 (3), p.840-845.e21

4.
Acute respiratory health effects of air pollution on children with asthma in US inner cities
by O'Connor, George T., MD, MS
Journal of allergy and clinical immunology, 2008, Vol.121 (5), p.1133-1139.e1

5.
Polymorphic microsatellites and Wilson disease (WD)
by STEWART, E. A
American journal of human genetics, 1993, Vol.53 (4), p.864-873

6.
Differential effects of outdoor versus indoor fungal spores on asthma morbidity in inner-city children
by Pongracic, Jacqueline A., MD
Journal of allergy and clinical immunology, 2010, Vol.125 (3), p.593-599

7.
Parental characteristics, somatic fetal growth, and season of birth influence innate and adaptive cord blood cytokine responses
by Gold, Diane R., MD, MPH
Journal of allergy and clinical immunology, 2009, Vol.124 (5), p.1078-1087

8.
Outbreak of Neisseria meningitidis serogroup C outside the meningitis belt—Liberia, 2017: an epidemiological and laboratory investigation
by Bozio, Catherine H Catherine H
The Lancet infectious diseases, 2018-10-15, Vol.18 (12), p.1360-1367

9.
Is the association between childhood socioeconomic circumstances and cause-specific mortality established? Update of a systematic review
by Galobardes, B
Journal of epidemiology and community health (1979), 2008-05, Vol.62 (5), p.387-390

10.
Exercise-induced muscle damage and the repeated bout effect: evidence for cross transfer
by Starbuck, Chelsea
European journal of applied physiology, 2011-07-01, Vol.112 (3), p.1005-1013

11.
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
by Grothey, Axel, MD
The Lancet (British edition), 2013, Vol.381 (9863), p.303-312

12.
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data...
by Emberson, Jonathan, PhD
The Lancet (British edition), 2014, Vol.384 (9958), p.1929-1935

13.
Indicators of socioeconomic position (part 2)
by Galobardes, Bruna
Journal of epidemiology and community health (1979), 2006-02, Vol.60 (2), p.95-101

14.
Ambulatory Blood Pressure Patterns in Children With Chronic Kidney Disease
by Samuels, Joshua
Hypertension (Dallas, Tex. 1979), 2012-07, Vol.60 (1), p.43-50

15.
The effects of exercise-induced muscle damage on maximal intensity intermittent exercise performance
by Twist, Craig
European journal of applied physiology, 2005-08, Vol.94 (5-6), p.652-658

16.
Changes in performance, skinfold thicknesses, and fat patterning after three years of intense athletic conditioning in high level runners
by Legaz, A
British journal of sports medicine, 2005-11, Vol.39 (11), p.851-856

17.
Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-...
by Demetri, George D, Prof
The Lancet (British edition), 2013, Vol.381 (9863), p.295-302

18.
Explaining the social gradient in coronary heart disease: comparing relative and absolute risk approaches
by Lynch, John
Journal of epidemiology and community health (1979), 2006-05, Vol.60 (5), p.436-441

19.
Dexamethasone Posterior-Segment Drug Delivery System in the Treatment of Macular Edema Resulting from Uveitis or Irvine-Gass Syndrome
by Williams, George A
American journal of ophthalmology, 2009, Vol.147 (6), p.1048-1054.e2

20.
Ritonavir-boosted darunavir combined with raltegravir or tenofovir–emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 random...
by Raffi, François, Prof
The Lancet (British edition), 2014, Vol.384 (9958), p.1942-1951
